object
determin
median
infect
dose
id
cryptosporidium
parvum
describ
doserespons
relationship
includ
associ
clinic
ill
experiment
challeng
dairi
calv
within
first
h
life
test
calv
experiment
challeng
c
parvum
oocyst
control
calv
sham
dose
test
calv
receiv
possibl
dose
oocyst
test
calv
develop
diarrhea
fecal
oocyst
shed
occur
test
calv
control
calv
nonshed
test
calv
receiv
oocyst
invers
relationship
dose
time
onset
fecal
oocyst
shed
p
relationship
found
dose
durat
p
cessat
p
fecal
oocyst
shed
addit
signific
relationship
logdos
logpeak
oocyst
p
logtot
oocyst
p
countedg
fece
across
dose
group
posit
doserespons
relationship
logdos
diarrhea
p
howev
control
factor
onset
cessat
fecal
oocyst
shed
dose
signific
predictor
diarrhea
p
onset
cessat
fecal
oocyst
shed
found
best
predictor
diarrhea
p
p
respect
id
fecal
oocyst
shed
oocyst
diarrhea
oocyst
fecal
oocyst
shed
diarrhea
oocyst
given
id
c
parvum
far
less
would
excret
environ
natur
infect
calf
prevent
control
cryptosporidiosi
formid
challeng
object
determin
median
infect
dose
id
cryptosporidium
parvum
describ
doserespons
relationship
includ
associ
clinic
ill
experiment
challeng
dairi
calv
within
first
h
life
test
calv
experiment
challeng
c
parvum
oocyst
control
calv
sham
dose
test
calv
receiv
possibl
dose
oocyst
test
calv
develop
diarrhea
fecal
oocyst
shed
occur
test
calv
control
calv
nonshed
test
calv
receiv
oocyst
invers
relationship
dose
time
onset
fecal
oocyst
shed
p
relationship
found
dose
durat
p
cessat
p
fecal
oocyst
shed
addit
signific
relationship
logdos
logpeak
oocyst
p
logtot
oocyst
p
countedg
fece
across
dose
group
posit
doserespons
relationship
logdos
diarrhea
p
howev
control
factor
onset
cessat
fecal
oocyst
shed
dose
signific
predictor
diarrhea
p
onset
cessat
fecal
oocyst
shed
found
best
predictor
diarrhea
p
p
respect
id
fecal
oocyst
shed
oocyst
diarrhea
oocyst
fecal
oocyst
shed
diarrhea
oocyst
given
id
c
parvum
far
less
would
excret
environ
natur
infect
calf
prevent
control
cryptosporidiosi
formid
challeng
elsevi
bv
right
reserv
cryptosporidium
genu
apicomplexan
protozo
parasit
global
distribut
known
infect
sever
speci
anim
fayer
cryptosporidium
parvum
cryptosporidium
homini
respect
hostadapt
cattl
peopl
recogn
among
pathogen
speci
cryptosporidiosi
refer
infect
cryptosporidium
spp
primarili
character
villu
atrophi
fusion
intestin
crypt
inflamm
result
malabsorpt
maldigest
osmot
diarrhea
c
parvum
infect
typic
occur
calv
less
month
old
impact
calf
morbid
mortal
ohandley
et
al
infect
calv
shed
larg
number
readili
infect
oocyst
fece
impact
environment
parasit
load
nydam
et
al
c
parvum
infect
import
zoonosi
caus
similar
clinic
symptom
peopl
like
acquir
immun
suppress
individu
anderson
transmiss
typic
via
fecalor
rout
common
risk
factor
cryptosporidiosi
includ
ingest
contamin
water
ie
fecal
accid
public
swim
pool
use
unprotect
water
sourc
poor
hygien
contact
livestock
failur
municip
watertreat
facil
mackenzi
et
al
valderrama
et
al
ng
et
al
current
consist
effect
commerci
avail
treatment
vaccin
nitazoxanid
ntz
shown
efficaci
hivseroneg
patient
hivseroposit
patient
amadi
et
al
ntz
reduc
fecal
oocyst
shed
calv
commerci
avail
use
cattl
ollivett
et
al
given
challeng
cryptosporidiosi
calf
manag
concern
also
global
public
health
concern
handley
et
al
thompson
et
al
doserespons
relationship
describ
median
infect
dose
id
determin
cryptosporidium
spp
investig
carri
healthi
human
volunt
c
parvum
c
homini
posit
relationship
size
inoculum
occurr
enter
symptom
confirm
thu
larger
exposur
infect
oocyst
wors
clinic
outcom
dupont
et
al
chappel
et
al
peopl
experiment
infect
c
parvum
c
homini
develop
enter
symptom
dupont
et
al
chappel
et
al
human
subject
develop
diarrhea
excret
oocyst
median
infect
dose
id
c
parvum
determin
oocyst
c
homini
oocyst
dupont
et
al
chappel
et
al
similar
studi
anim
restrict
laboratori
speci
report
id
c
parvum
immunocompet
neonat
mice
oocyst
neonat
mice
oocyst
consist
dose
report
peopl
ernest
et
al
finch
et
al
experiment
infect
livestock
report
literatur
studi
natur
infect
conduct
natur
infect
calv
experi
diarrhea
mean
onset
fecal
oocyst
shed
day
mean
durat
fecal
oocyst
shed
day
ohandley
et
al
though
shown
conclus
studi
natur
infect
calv
suggest
reduc
exposur
c
parvum
oocyst
result
reduc
durat
fecal
oocyst
shed
moor
et
al
even
though
studi
natur
infect
provid
import
inform
diseas
ecolog
limit
confound
coinfect
lack
experiment
control
given
c
parvum
known
zoonosi
preval
us
dairi
herd
contribut
increas
calf
mortal
avail
pharmacolog
intervent
import
improv
understand
c
parvum
epidemiolog
experiment
studi
infect
order
develop
appropri
diseas
control
prevent
strategi
lefay
et
al
trotzwilliam
et
al
tzipori
widmer
object
studi
determin
median
infect
dose
id
c
parvum
describ
doserespons
relationship
associ
clinic
ill
experiment
challeng
dairi
calv
challeng
model
calf
enrol
calv
use
studi
care
complianc
cornel
univers
institut
anim
care
use
committe
iacuc
random
doubleblind
studi
perform
colleg
veterinari
medicin
cornel
univers
ithaca
ny
februari
march
thirti
calv
purchas
birth
local
dairi
farm
enrol
studi
born
control
calv
n
enrol
concurr
test
calv
n
least
one
studi
author
attend
calv
perineum
dam
thoroughli
clean
povidoneiodin
scrub
calv
deliv
onto
singleus
plastic
sheet
prevent
manur
contamin
immedi
birth
physic
examin
perform
identif
tag
place
right
ear
calv
fed
l
g
iggl
commerci
colostrum
replac
bovin
igg
colostrum
replac
land
olak
inc
st
paul
mn
within
first
h
life
via
oroesophag
feed
tube
order
replic
convent
calf
manag
commerci
dairi
best
possibl
commerci
colostrum
replac
fed
instead
colostrum
order
minim
variabl
calv
limit
potenti
pathogen
exposur
provid
adequ
passiv
transfer
immun
without
provid
anticryptosporidium
specif
antibodi
calv
transport
sourc
farm
cornel
univers
cornel
univers
calv
hous
biosafeti
level
facil
individu
concret
box
stall
blood
sampl
collect
calf
within
h
life
serum
total
protein
measur
order
assess
adequaci
passiv
transfer
calv
fed
commerci
fat
nonmed
milk
replac
nurs
formula
nt
calf
milk
replac
land
olak
inc
least
kg
dri
matter
per
day
split
feed
durat
studi
water
provid
ad
libitum
enrol
control
test
calv
random
dose
group
number
gener
calv
receiv
oral
challeng
c
parvum
oocyst
within
first
h
life
three
calv
serv
control
sham
dose
oocyst
twentyseven
calv
inocul
one
eight
possibl
dose
genotyp
field
strain
c
parvum
oocyst
five
calv
receiv
oocyst
calv
receiv
oocyst
calv
receiv
oocyst
studi
personnel
blind
dose
group
control
calv
n
hous
facil
test
calv
sham
dose
manag
test
calv
order
maintain
blind
control
calv
also
serv
sentinel
cross
contamin
test
calv
help
maintain
qualiti
assur
data
collect
husbandri
practic
prevent
cross
contamin
calv
fed
bed
order
youngest
oldest
day
calf
stall
dedic
equip
suppli
studi
personnel
use
singleus
person
protect
equip
enter
calf
stall
fecal
sampl
collect
calf
everi
h
oral
challeng
clinic
data
includ
rectal
temperatur
gener
health
statu
fecal
consist
record
everi
h
calf
health
statu
assess
scale
fecal
consist
assess
scale
accord
previous
describ
method
tabl
bellosa
et
al
diarrhea
defin
least
consecut
fecal
consist
score
calv
shed
oocyst
fece
enrol
studi
day
calv
oocyst
present
fece
enrol
studi
consecut
neg
fecal
exam
record
onset
fecal
shed
calv
test
presenc
rotaviru
coronaviru
salmonella
spp
oocyst
use
dose
calv
purifi
use
procedur
previous
describ
jenkin
et
al
brief
fece
collect
natur
infect
calv
separ
commerci
dairi
oper
process
continuousflow
differenti
densiti
flotat
store
need
c
suspens
u
penicillin
g
sodium
per
ml
mg
streptomycin
sulfat
per
ml
mg
amphotericin
b
per
ml
oocyst
dna
genotyp
c
parvum
sequenc
restrict
fragment
length
polymorph
analysi
via
amplif
small
subunit
ssu
rrna
gene
nest
polymeras
chain
reaction
pcr
describ
previous
jiang
et
al
brief
primari
pcr
step
amplifi
fragment
approxim
base
pair
wherea
secondari
pcr
step
result
fragment
approxim
base
pair
primari
pcr
follow
forward
revers
primer
use
respect
secondari
pcr
follow
forward
revers
primer
use
respect
inocul
oocyst
first
clean
one
minut
sodium
hypochlorit
inactiv
virus
bacteria
copurifi
oocyst
wash
four
time
phosphat
buffer
salin
remov
sodium
hypochlorit
quantifi
use
hemocytomet
final
viabil
determin
use
dye
permeabl
assay
describ
previous
campbel
et
al
anguish
ghiors
jenkin
et
al
viabl
oocyst
sum
propidium
iodideneg
oocyst
dapiposit
dapi
oocyst
dapi
pi
oocyst
consid
inactiv
jenkin
et
al
oocyst
use
dose
least
viabl
dose
calcul
base
percent
viabl
dose
administ
ml
suspens
c
parvum
oocyst
revers
osmosi
water
via
rigid
portion
oroesophag
feed
tube
follow
ml
water
ensur
oocyst
suspens
deliv
calf
quantit
analysi
c
parvum
oocyst
fecal
sampl
collect
perform
use
merifluor
cryptogiardia
immunofluoresc
antibodi
detect
reagent
meridian
diagnost
cincinnati
oh
xiao
herd
immunofluoresc
procedur
modifi
kit
instruct
briefli
g
portion
fece
mix
ml
pb
ph
ml
conic
centrifug
tube
l
mixtur
remov
l
merifluor
immunofluoresc
antibodi
reagent
ad
solut
vortex
incub
dark
room
temperatur
least
min
store
c
examin
follow
incub
l
sampl
place
slide
cover
coverslip
object
fluoresc
compound
binocular
microscop
wavelength
fluoresc
compound
binocular
microscop
olympu
olympu
america
inc
center
valley
pa
use
count
number
oocyst
observ
number
oocyst
observ
l
multipli
give
number
oocyst
per
gram
fece
count
standard
dri
weight
percentag
dri
weight
analysi
fecal
sampl
obtain
take
g
portion
origin
fecal
sampl
dri
c
minimum
h
thermolyn
mechan
oven
barnstead
intern
dubuqu
ia
weigh
directli
precis
standard
scale
ohau
corpor
pine
brook
nj
bellosa
et
al
data
analyz
use
descript
inferenti
method
use
shapirowilk
test
data
determin
nongaussian
wilcoxon
rank
sum
test
use
compar
set
continu
data
dose
group
probabl
shed
given
day
challeng
estim
use
kaplanmei
product
limit
method
kaplan
meier
post
hoc
analysi
percentag
fecal
score
across
dose
group
carri
dunn
post
test
analysi
varianc
use
assess
differ
fecal
oocyst
count
across
dose
group
simpl
linear
regress
analysi
use
evalu
relationship
individu
explanatori
variabl
diarrhea
percent
fecal
score
well
onset
fecal
oocyst
shed
explanatori
variabl
p
select
analysi
use
multipl
linear
regress
manual
backwardstepwis
regress
use
remov
explanatori
variabl
interact
model
p
id
fecal
oocyst
shed
diarrhea
fecal
oocyst
shed
diarrhea
estim
use
linear
regress
analysi
percent
dose
calv
shed
oocyst
stool
develop
diarrhea
compar
total
number
calv
receiv
dose
oocyst
log
transform
dupont
et
al
data
analyz
use
jmp
sa
institut
inc
inc
calv
enrol
studi
control
calv
experiment
challeng
cryptosporidium
parvum
oocyst
calv
enrol
studi
day
time
mean
number
fecal
score
record
mean
number
health
score
record
across
group
mean
serum
total
protein
measur
gdl
ci
differ
group
p
none
calv
test
posit
coinfect
rotaviru
coronaviru
salmonella
spp
none
control
calv
develop
diarrhea
fecal
oocyst
shed
experiment
challeng
calv
develop
diarrhea
least
consecut
fecal
consist
score
twentyf
calv
shed
c
parvum
oocyst
fece
calv
nonshed
calv
challeng
oocyst
mean
time
onset
fecal
oocyst
shed
day
ci
n
tabl
invers
relationship
dose
time
onset
fecal
oocyst
shed
ie
calv
receiv
smaller
dose
began
shed
later
p
logdos
increas
time
onset
fecal
oocyst
shed
shorten
day
p
fig
dose
group
calv
receiv
oocyst
shed
later
calv
receiv
oocyst
p
p
respect
fig
mean
durat
fecal
oocyst
shed
day
ci
tabl
mean
median
rang
number
day
postchalleng
onset
fecal
shed
number
day
durat
fecal
shed
postchalleng
number
day
postchalleng
cessat
fecal
shed
calv
experiment
challeng
oocyst
c
parvum
n
tabl
mean
time
cessat
fecal
oocyst
shed
day
ci
n
tabl
dose
influenc
durat
fecal
oocyst
shed
p
cessat
fecal
oocyst
shed
p
howev
higher
dose
variabl
observ
durat
cessat
fecal
oocyst
shed
tabl
dose
group
collaps
dose
level
oocyst
oocyst
oocyst
differ
time
onset
across
level
p
dose
level
calv
receiv
oocyst
shed
later
calv
receiv
oocyst
p
p
respect
fig
show
probabl
onset
fecal
oocyst
shed
given
day
postchalleng
dose
level
fecal
shed
diarrhea
occur
dose
invers
relationship
onset
fecal
oocyst
shed
diarrhea
ie
calv
began
shed
oocyst
sooner
dose
experienc
day
diarrhea
p
fig
logpeak
oocyst
count
ci
logtot
oocyst
count
ci
differ
logpeak
logtot
oocyst
countedg
fece
across
dose
group
p
p
respect
among
dose
level
p
p
respect
among
calv
dose
oocyst
calv
shed
oocyst
also
develop
diarrhea
remain
dose
calv
shed
develop
diarrhea
tabl
health
score
occur
calv
occur
calf
calf
health
score
sever
consecut
day
calf
septic
stifl
joint
secondari
umbil
abscess
exclud
health
score
analysi
includ
analysi
explanatori
variabl
logdos
total
protein
day
enrol
weight
day
enrol
weight
final
day
enrol
onset
fecal
oocyst
shed
durat
fecal
oocyst
shed
cessat
fecal
oocyst
shed
logpeak
number
fecal
oocyst
count
logtot
number
fecal
oocyst
count
evalu
via
simpl
linear
regress
evalu
possibl
relationship
diarrhea
tabl
variabl
logdos
weight
final
day
enrol
onset
fecal
oocyst
shed
cessat
fecal
oocyst
shed
pvalu
retain
analysi
via
multipl
linear
regress
final
model
onset
cessat
fecal
oocyst
shed
found
best
predictor
diarrhea
p
p
respect
tabl
simpl
linear
regress
also
conduct
use
explanatori
variabl
evalu
relationship
onset
fecal
oocyst
shed
tabl
logdos
durat
fecal
oocyst
shed
cessat
fecal
oocyst
shed
found
pvalu
retain
analysi
via
multipl
linear
regress
best
predictor
onset
fecal
oocyst
shed
durat
cessat
fecal
oocyst
shed
p
predictor
tabl
posit
relationship
logdos
fecal
oocyst
shed
diarrhea
p
fig
well
logdos
diarrhea
alon
p
id
shed
oocyst
diarrhea
oocyst
shed
diarrhea
oocyst
tabl
linear
regress
analysi
data
yield
oocyst
fecal
oocyst
shed
oocyst
diarrhea
oocyst
fecal
oocyst
shed
diarrhea
simpl
linear
regress
analysi
evalu
relationship
individu
explanatori
variabl
two
possibl
outcom
diarrhea
onset
fecal
oocyst
shed
studi
demonstr
posit
doserespons
relationship
c
parvum
infect
fecal
oocyst
shed
diarrhea
determin
neonat
dairi
calv
id
c
parvum
oocyst
depend
clinic
definit
infect
appli
dose
order
magnitud
less
number
oocyst
typic
shed
environ
natur
infect
calv
report
excess
oocyst
calf
shed
oocyst
day
nydam
et
al
current
studi
calv
receiv
lowest
dose
c
parvum
oocyst
began
fecal
oocyst
shed
later
associ
fewer
day
diarrhea
given
c
parvum
preval
dairi
calv
ubiquit
environ
difficult
kill
control
pose
challeng
dairi
farmer
fayer
et
al
trotzwilliam
et
al
fecalor
transmiss
cycl
know
small
level
exposur
result
larg
amount
fecal
oocyst
shed
know
exactli
mani
oocyst
calf
expos
given
day
pose
greatest
challeng
control
howev
like
calf
exposur
greatli
exce
id
report
therefor
find
studi
suggest
unless
c
parvum
complet
elimin
environ
difficult
reduc
incid
cryptosporidiosi
previou
studi
report
mean
onset
fecal
oocyst
shed
day
experiment
challeng
calv
day
natur
infect
calv
ohandley
et
al
moor
et
al
studi
healthi
human
volunt
report
averag
onset
fecal
oocyst
shed
day
dupont
et
al
found
invers
relationship
onset
fecal
oocyst
shed
dose
calv
receiv
smaller
dose
began
shed
later
also
found
prior
studi
zambriski
et
al
likewis
dupont
et
al
report
relationship
onset
fecal
oocyst
shed
peopl
size
oral
inoculum
ie
higher
dose
infect
tend
occur
sooner
last
longer
studi
calv
peopl
report
differ
relationship
durat
fecal
oocyst
shed
dose
dupont
et
al
moor
et
al
studi
moor
et
al
associ
dose
durat
fecal
oocyst
shed
report
studi
calv
die
among
calv
necropsi
found
coinfect
salmonella
spp
rotaviru
coronaviru
addit
c
parvum
therefor
possibl
relationship
report
dose
durat
fecal
shed
influenc
coinfect
studi
conduct
healthi
human
volunt
challeng
c
parvum
nonstatist
signific
relationship
report
dose
durat
oocyst
excret
author
discuss
possibl
reason
associ
respect
enter
symptom
moor
et
al
report
invers
relationship
onset
diarrhea
durat
diarrhea
calv
dupont
et
al
report
relationship
dose
occurr
enter
sign
studi
found
posit
relationship
dose
diarrhea
final
model
onset
cessat
fecal
oocyst
shed
found
better
predictor
diarrhea
explain
part
parasit
life
cycl
associ
patholog
gastrointestin
gi
tract
calv
shed
sooner
longer
may
like
experi
longer
autoinfect
stage
may
experi
recurr
villu
damag
time
could
result
longer
time
recoveri
heal
gi
tract
longer
sever
episod
diarrhea
depend
definit
infect
appli
id
c
parvum
calv
studi
rang
oocyst
knowledg
first
studi
report
inform
calv
speci
report
id
c
parvum
also
low
outbr
neonat
mice
oocyst
low
oocyst
wildtyp
neonat
mice
finch
et
al
dupont
et
al
immunosuppress
mongolian
gerbil
becom
infect
challeng
c
parvum
oocyst
baishanbo
et
al
healthi
human
volunt
id
report
oocyst
infect
occur
dose
level
includ
oocyst
dupont
et
al
infect
c
homini
healthi
human
volunt
id
estim
oocyst
chappel
et
al
studi
find
consist
report
research
illustr
point
dose
c
parvum
oocyst
requir
induc
ill
fecal
oocyst
shed
rel
low
compar
environment
load
sinc
studi
control
experiment
trial
studi
calv
maintain
clean
dri
hous
receiv
appropri
dri
matter
intak
challeng
gi
parasit
bacteria
virus
may
therefor
consid
better
overal
health
gener
popul
calv
north
american
dairi
farm
thu
research
translat
field
set
possibl
overestim
id
doserespons
relationship
sever
clinic
outcom
could
occur
given
none
control
calv
develop
diarrhea
fecal
oocyst
shed
unlik
cross
contamin
occur
challeng
calv
challeng
calv
expos
oocyst
quantiti
greater
initi
challeng
dose
studi
demonstr
calv
suscept
c
parvum
infect
low
dose
experi
clinic
ill
fecal
oocyst
shed
degre
fecal
oocyst
shed
associ
cryptosporidiosi
dramat
disproportion
id
c
parvum
contribut
environment
load
infect
subsequ
calv
studi
show
calv
receiv
lower
dose
began
shed
oocyst
later
associ
less
diarrhea
howev
calv
fare
better
clinic
perspect
differ
logtot
logpeak
oocyst
countedg
fece
across
dose
mean
regardless
level
exposur
degre
environ
load
unaffect
therefor
best
method
control
cryptosporidiosi
prevent
exposur
entir
howev
set
feasibl
keep
expos
calv
clean
dri
nourish
minim
impact
diseas
calf
health
wellb
ollivett
et
al
